USPTO Extends Madrid Protocol Info Collection Period
Published Date: 6/17/2025
Notice
Summary
The USPTO is asking for approval to keep collecting info about the Madrid Protocol, which helps people register trademarks internationally. This update affects businesses and individuals who file trademark applications and aims to keep paperwork easy and efficient. You’ve got 30 more days to share your thoughts before the final decision, and no new fees are involved.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Madrid Protocol Info Collection Continued
The USPTO is renewing its information collection for the Madrid Protocol (OMB control number 0651-0051), which supports international trademark registration. This renewal keeps the existing paperwork process in place and aims to minimize reporting burden for businesses and individuals who file trademark applications.
No New Fees for Madrid Filing
The USPTO states that this information collection renewal for the Madrid Protocol involves no new fees. If you are a business or individual filing international trademark applications, you will not face new charges from this renewal.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-14941, Grant of Interim Extension of the Term of U.S. Patent No. 8,461,196; Centanafadine Hydrochloride
Otsuka America Pharmaceutical got a one-year extra patent life for their drug centanafadine hydrochloride because the FDA review is still going on. This means they keep exclusive rights to the drug until July 25, 2027, giving them more time to sell it without competition. This extension helps the company protect their investment while the drug gets final approval.
2026-14939, Grant of Interim Extension of the Term of U.S. Patent No. 8,877,798; Centanafadine Hydrochloride
Otsuka America Pharmaceutical got a one-year extra patent life for their drug centanafadine hydrochloride because the FDA review is still going on. This means their patent, which was set to expire on July 25, 2026, now lasts until July 25, 2027. This extension helps Otsuka keep exclusive rights to their drug a bit longer while waiting for final FDA approval.
2026-14793, Requirement To Identify All Real Parties in Interest to a Third Party Request for an Ex Parte Reexamination
The USPTO wants anyone asking for a third-party ex parte reexamination to clearly say who’s really behind the request. This helps stop sneaky tricks and keeps the process honest. If you’re involved, get ready to share this info confidentially by August 21, 2026, or risk delays or issues.
2026-14388, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Admission to Practice and Roster of Registered Patent Attorneys and Agents Admitted to Practice Before the United States Patent and Trademark Office
The USPTO is asking for public feedback on its paperwork rules for patent attorneys and agents who want to practice before the office. This helps keep the process smooth and fair without making people fill out too many forms. If you have thoughts, send them in by August 17, 2026—no fees or big changes are happening right now, just a review.
2026-14389, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Response to Office Action and Voluntary Amendment Forms
The USPTO is asking for public feedback on updating forms used to respond to trademark office actions and make voluntary changes. This affects anyone applying for or managing trademarks and could streamline the process without extra costs. Comments are open until September 15, 2026, so don’t miss your chance to weigh in!
2026-14240, References to Electronic Filing Systems in Rules of Practice in Filings Pursuant to the Protocol Relating to the Madrid Agreement Concerning the International Registration of Marks
The USPTO is updating its rules to swap out specific electronic filing system names with more general terms for submitting international trademark applications under the Madrid Protocol. This change won’t affect how you file or any fees—it just makes the language clearer and easier to follow. The new rule kicks in on July 15, 2026, and applies to anyone filing international trademark paperwork from the U.S.
Previous / Next Documents
Previous: 2025-11112, Presidential Declaration of a Major Disaster for Public Assistance Only for the State of Missouri
President just declared a major disaster for Missouri because of severe storms, tornadoes, and flooding. This means local communities can get special help to fix public buildings and infrastructure. The aid starts now, so Missouri can bounce back faster and stronger!
Next: 2025-11114, Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; NTIA Internet Use Survey
The Department of Commerce wants your thoughts on a survey about how people use the internet. This helps make sure the questions aren’t too tricky or time-consuming. If you’re part of the public or a federal agency, you can comment for 60 days before the survey gets final approval—no money changes, just making things easier and clearer!